Transient elastography: A non-invasive tool for assessing liver fibrosis in HIV/HCV patients

Table 6 Correlation (r or ρ) between liver stiffness and studied parameters

	LS
	HIV	HCV	HIV/HCV
BMI	0.11	-0.1	0.02
HCV genotype 3/non 3	-	-0.1	-0.26
HCV-RNA	-	-	-0.26
HIV-RNA	0.21	-	0.18
Time HAART	-0.047	-	0.09
CD4 cells count	0.074	-	-0.32d
Alcohol	-0.096	0.70a	0.30e
T-Chol	-0.09	-0.32b	-0.18
TG	0.06	0.18	0.1
HDL-Chol	-0.1	0.05	-0.16
Diabetes + IFG	-0.01	0.19	0.14
Time HCV	-	0.24	-0.02
ALT	0.03	0.1	0.23
AST	0.18	0.56c	0.40a
Platelets	-0.02	-0.56c	-0.61c
APRI score	0.04	0.70c	0.50c
FIB-4 score	0.06	0.75c	0.60c

LS: Liver stiffness; HIV: Human immunodeficiency virus; HCV: Hepatitis C virus; BMI: Body mass index; HAART: Highly active anti-retroviral therapy; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; T-Chol: Total cholesterol; HDL: High density lipoprotein; TG: Triglyceride; IFG: Impaired fasting glucose; APRI: Aminotransferase platelet ratio index.

^aP < 0.001;

^bP < 0.03;

^cP < 0.0001;

^dP < 0.02;

^eP < 0.04.